The company has begun advising enterprise customers that Adobe product users will be required to change their account password at their next login attempt.
The breach does not affect users of Adobe Creative Cloud or Digital Publishing Suite -- other than a password reset.
Adobe will also be sending notification letters over the next two weeks to customers whose individual accounts were breached.
The fact that it took an expos茅 by krebsonsecurity.com to prompt Adobe to alert customers of this devastating breach is not surprising, says Peter Toren, a former federal prosecutor of computer crimes, who is now with Weisbrod Matteis & Copley.
Top 5 Communications Equipment Companies For 2015: Ishares Msci Switzerland (EWL)
iShares MSCI Switzerland Index Fund (the Fund) seeks to provide investment results that correspond generally to the price and yield performance of publicly traded securities in the aggregate in the Swiss market, as measured by the MSCI Switzerland Index (the Index). The Index seeks to measure the performance of the Swiss equity market. The Index is a capitalization-weighted index that aims to capture 85% of the (publicly available) total market capitalization. Component companies are adjusted for available float and must meet objective criteria for inclusion in the Index. The Index is reviewed quarterly.
The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. The Fund�� investment advisor is Barclays Global Fund Advisors.
Advisors' Opinion:- [By Mark Salzinger]
iShares MSCI Germany (EWG) and iShares MSCI Switzerland (EWL) continue to have relatively attractive valuations.
EWG recently sported an average price/earnings (P/E) ratio on 2013's projected earnings of 12.6 and a price/book value (P/B) of just 1.4.
- [By Carlton Delfeld]
The iShares Switzerland (EWL) is a wonderful way to gain exposure to a basket of Switzerland's leading multinationals and has an expense ratio of only 0.59%. In addition, while a rising Swiss franc puts pricing pressure on Swiss exporters, a strong Swiss franc supercharges returns for investors in EWL.
10 Best Rising Stocks To Watch For 2014: Flagstar Bancorp Inc (FBC)
Flagstar Bancorp, Inc. incorporated on October 28, 1993, is a savings and loan holding company. The Company�� business is primarily conducted through its principal subsidiary, Flagstar Bank, FSB (the Bank), a federally chartered stock savings bank. At December 31, 2012, its total assets were $ $14.1 billion. The Bank�� wholly owned subsidiary is Flagstar Capital Markets Corporation (FCMC). The Company operates in two segments: Community Banking and Mortgage Banking. The Community Banking segment offers a line of financial products and services to individuals, small and middle market businesses, and mortgage lenders. Its Mortgage Banking segment originates, acquires, sells and services residential first mortgage loans on one-to-four family residences. The Bank�� Other segment include corporate treasury, tax benefits not assigned to specific operating segments, and miscellaneous other expenses of a corporate nature.
Community Banking
Community Banking segment includes Branch Banking, Commercial and Business Banking, Government Banking, and Warehouse Lending. Community Banking segment originates loans and deposits to consumer, business and mortgage lending customers through its Branch Banking, Business and Commercial Banking, Government Banking, and Warehouse Lending groups. Products offered include checking accounts, savings accounts, money market accounts, certificates of deposit, consumer loans, commercial loans and warehouse lines of credit. Other financial services available to consumer and commercial customers include lines of credit, revolving credit, customized treasury management solutions, equipment leasing, inventory and accounts receivable lending and capital markets services such as interest rate risk protection products. At December 31, 2012, Branch Banking included 111 banking centers located throughout Michigan. As of December 31, 2012, the commercial loans held-for-investment totaled $0.7 billion, and consisted of commercial real estate, commercial and in! dustrial and commercial lease financing. At December 31, 2012, its commercial real estate loans held-for-investment totaled $640.3 million.
Commercial and industrial held-for-investment loan facilities include lines of credit to its small or middle market businesses for use in normal business operations to finance working capital needs, equipment purchases and expansion projects. At December 31, 2012 its commercial and industrial held-for-investment loans totaled $90.6 million. Its commercial lease financing held-for-investment loan portfolio is comprised of equipment leased to customers in a direct financing lease. At December 31, 2012 its commercial lease financing held-for-investment loans totaled $6.3 million. The Company offers warehouse lines of credit to other mortgage lenders. As of December 31, 2012, there were 311 warehouse lines of credit to other mortgage lenders with an average size of $7.5 million.
Mortgage Banking
The Company�� Mortgage Banking segment originates, acquires, sells and services one-to-four family residential first mortgage loans. Mortgage loans are originated through home lending centers, national call centers, the Internet, unaffiliated banks and mortgage brokerage companies. Also, the Mortgage Banking segment services mortgage loans for others and sells MSRs into the secondary market.
In a home lending center transaction, loans are originated through a network of its loan origination centers, as well as referrals from its Banking segment and the national call center. At December 31, 2012, the Company maintained 31 loan origination centers. In a broker transaction, an unaffiliated bank or mortgage brokerage company completes the loan paperwork, but the loans are underwritten on a loan-level basis to its underwriting standards and it supplies the funding for the loan at closing thereby becoming the lender of record. As of December 31, 2012, the Company had active broker relationships with over 1,700 banks, credit unions! , and mor! tgage brokerage companies. In a correspondent transaction, an unaffiliated bank or mortgage company completes the loan paperwork and also supplies the funding for the loan at closing. As of December 31, 2012, the Bank had active correspondent relationships with over 1,300 companies, including banks, credit unions, and mortgage companies.
Advisors' Opinion:- [By Brian Pacampara]
What: Shares of mortgage insurer MBIA (NYSE: MBI) climbed 10% today after settling its lawsuit against Flagstar Bancorp (NYSE: FBC), in which it accused the bank of misrepresenting the loan quality underlying $1.1 billion in mortgage-backed securities. �
10 Best Rising Stocks To Watch For 2014: Galena Biopharma Inc (GALE)
Galena Biopharma, Inc. (Galena), formerly RXi Pharmaceuticals Corporation, incorporated on April 3, 2006, is a biotechnology company focused on discovering, developing and commercializing therapies addressing unmet medical needs using targeted biotherapeutics. The Company is pursuing the development of cancer therapeutics using peptide-based immunotherapy products, including its main product candidate, NeuVaxTM (E75), for the treatment of breast cancer and other tumors. NeuVax is a peptide-based immunotherapy intended to reduce the recurrence of breast cancer in low-to-intermediate HER2-positive breast cancer patients not eligible for trastuzumab (Herceptin; Genentech/Roche). On January 19, 2012, the Company initiated enrollment in its Phase 3 PRESENT clinical trial for NeuVax (E75 peptide plus GM-CSF) vaccine in low-to-intermediate HER2 1+ and 2+ breast cancer patients in the adjuvant setting to prevent recurrence (Clinicaltrials.gov identifier NCT01479244). The Prevention of Recurrence in Early-Stage, Node-Positive Breast Cancer with Low to Intermediate HER2 Expression with NeuVax Treatment study is a randomized, multicenter, multinational clinical trial that will enroll approximately 700 breast cancer patients. The Company�� Phase 2 trial of NeuVax achieved its primary endpoint of disease-free survival (DFS). On April 13, 2011, the Company completed its acquisition of Apthera, Inc.,(Apthera).
The Company focuses to start a Phase 2 trial comparing NeuVax in combination with trastuzumab (Herceptin) versus trastuzumab, alone, in a 300-patient, randomized study in the adjuvant breast cancer setting. The Company's second product candidate, Folate Binding Protein-E39 (FBP), is a vaccine, consisting of the peptides E39 and J65, aimed at preventing the recurrence of ovarian, endometrial, and breast cancers. On February 14, 2012, the Company announced the initiation of a Phase 1/2 clinical trial in two gynecological cancers: ovarian and endometrial adenocarcinomas. Folate binding protein has ! very limited tissue distribution and expression in non-malignant tissue and is over-expressed in more than 90% of ovarian and endometrial cancers, as well as in 20% to 50% of breast, lung, colorectal and renal cell carcinomas.
In April 2011, the Company acquired Apthera Inc and its NeuVax product candidate. The Company focuses on developing a pipeline of immunotherapy product candidates for the treatment of various cancers based on the E75 peptide, the advanced of which is NeuVax, which is targeted at preventing the recurrence of breast cancer. NeuVax has had positive Phase 1/2 clinical trial results for the prevention of breast cancer recurrence in patients who have had breast cancer and received the standard of care treatment (surgery, chemotherapy, radiotherapy and hormonal therapy as indicated). The Company had also initiated its Phase 3 PRESENT clinical trial of NeuVax for the prevention of breast cancer recurrence in early-stage low-to-intermediate HER2 breast cancer patients. NeuVax directs killer T-cells to target and destroy cancer cells that express HER2/neu, a protein associated with epithelial tumors in breast, ovarian, pancreatic, colon, bladder and prostate cancers. NeuVax is comprised of a HER2/neu-derived peptide called E75. E75 is a nine-amino acid sequence that is immunogenic (produces an immune response) and GM-CSF is a commercially available protein that acts to stimulate and activate components of the immune system such as macrophages and dendritic cells.
The Company also develops novel applications for NeuVax based on preclinical studies and phases 2 clinical trials which suggest that combining NeuVax and trastuzumab (Herceptin; Genentech/Roche) can increase antigen presentation by tumor cells by promoting receptor internalization and subsequent proteosomal degradation of the HER2 protein. The Company also is pursuing additional therapeutic indications for NeuVax that are in Phase 1/2 clinical trials. RXI-109, is a dermal anti-scarring therapy that targets! connecti! ve tissue growth factor (CTGF) and that may inhibit connective tissue formation in human fibrotic disease.
The Company competes with Roche Laboratories, Inc., Pfizer Inc., Bayer HealthCare AG, Sanofi-Aventis, US, LLC, Amgen, Inc., GlaxoSmithKline plc, Renovo Group plc, CoDa Therapeutics, Inc., Sirnaomics, Inc., FirstString Research, Inc., Merz Pharmaceuticals, LLC, Capstone Therapeutics, Halscion, Inc., Garnet Bio Therapeutics, Inc., AkPharma Inc., Promedior, Inc., Kissei Pharmaceutical Co., Ltd., Eyegene, Derma Sciences, Inc., Healthpoint Biotherapeutics, Pharmaxon, Excaliard Pharmaceuticals, Inc., Alnylam Pharmaceuticals, Inc., Marina Biotech, Inc., Tacere Therapeutics, Inc., Benitec Limited, OPKO Health, Inc., Silence Therapeutics plc, Quark Pharmaceuticals, Inc., Rosetta Genomics Ltd., Lorus Therapeutics, Inc., Tekmira Pharmaceuticals Corporation, Arrowhead Research Corporation, Regulus Therapeutics Inc. and Santaris.
Advisors' Opinion:- [By James E. Brumley]
It may look like little more than a choppy mess with just a quick glance at Galena Biopharma Inc. (NASDAQ:GALE). But, the more you study the chart - and the company - the more you realize there's enough long-term potential from the company's pipeline to keep spurring GALE in a generally-upward direction. In fact, the bulls look like they're on the verge of taking Galena Biopharma out of second gear and putting it into third. As such, it may not be a bad bet at this point.
- [By Paul Ausick]
Stocks on the move: Galena Biopharma Inc. (NASDAQ: GALE) is down 15.4% at $1.93 after pricing a secondary offering of 17.5 million units at $2.00. Safeway Inc. (NYSE: SWY) is up 6.1% at $28.21, after an analyst�� upgrade which sent shares to a new 52-week high of $28.88 earlier. Avanir Pharmaceuticals Inc. (NASDAQ: AVNR) is down 18.2% at $4.08.
- [By Michael Douglass and David Williamson]
Galena Biopharma� (NASDAQ: GALE ) announced this morning that it has licensed the rights to sell Zuplenz for $5 million in stock and cash, in addition to royalties, milestones, and an upfront payment.
10 Best Rising Stocks To Watch For 2014: Vision Industries Corp (VIIC)
Vision Industries Corp. (Vision), incorporated on May 11, 2004, is a manufacturer of zero-emission hydrogen fuel cell electric hybrid powered Class 8 trucks and terminal tractors. Vision operates in the short-haul, drayage trucking category (the movement of containerized cargo over a short distance, typically less than 50 miles, from a port to an intermodal facility, such as a rail yard). The Company�� products include the Tyrano, a short-haul Class 8 tractor, and the Zero-TT, a single axle terminal tractor co-developed with Cargotec USA, the maker of terminal tractors.
The Company markets its vehicles to drayage operators at the twin Ports of Los Angeles and Long Beach and plans to expand its target market nationally to all fleet operators, owner-operators and Original Equipment Manufacturers (OEMs). Vision aims to target drayage trucking fleet operators who operate in the eight deep-water ports (Los Angeles, Long Beach, Oakland, Seattle, Houston, Savanah, New York and New Jersey). Fleets which operate at these locations usually have predetermine routes, travel less than 50-mile (from Port to rail yard or distribution center) and have a return to base duty-cycle.
Tyrano
The Vision Tyrano is a lass 8 Zero-Emission Hydrogen Fuel Cell / Electric Hybrid heavy-duty truck designed to move containerized cargo from port to rail yard. With a GCVWR the Tyrano uses Lithium-ion batteries to power an electric motor and Hydrogen fuel cells to extend its range. The Vision Tyrano was designed for short-distance containerized cargo movement with trade corridor communities in mind.
Vision (Zero-TT) Terminal Tractors
The Zero-Emission Terminal Tractor (Zero-TT) is a Class 8 facility-only Hydrogen Fuel Cell Electric Hybrid vehicle. GCVWR and is designed to move the heavy containerized cargo inside a Port facility or central distribution center. The Zero-TT is designed to operate for two full eight-hour shifts with refillable hydrogen tanks.
The Cheetah Supercar is a zero-emission passenger sports car prototype. This sports car is using Vision�� hybrid hydrogen drive system which can deliver 425 horsepower and 1,350 feet /lbs of torque.
The Company competes with Bosch, Delphi, Siemens, Visteon, Quantum, Dynetek Industries Ltd., Lincoln Composites, Structural Composites Inc, Linde AG, Air Products and Energy Conversion Devices.
Advisors' Opinion:- [By Peter Graham]
Small cap green stocks Vision Industries Corp (OTCMKTS: VIIC), Bravo Enterprises Ltd (OTCMKTS: OGNG) and Kleangas Energy Technologies Inc (OTCMKTS: KGET) have reported recent news and/or they are being promoted. Of course, it goes without saying that small cap green stocks tend to be more volatile that other types of investments. So will investors and traders alike see some greenbacks from these green stocks? Here is a quick reality check:
10 Best Rising Stocks To Watch For 2014: Dollar/Yen (YY)
YY Inc., through its subsidiaries, operates an online social platform in the People�s Republic of China. It provides YY Client, a personal computer based user software that offers real-time access to user-created online social activities groups. The company also offers Web-based YY that enables users to conduct real-time interactions on the Web without any downloads or installations; and Mobile YY, a smartphone application. In addition, it operates Duowan.com, a game media Website that provides information on online games and other resources for users and online game players. The company was founded in 2005 and is based in Guangzhou, the People�s Republic of China.
Advisors' Opinion:- [By MONEYMORNING]
Just look at what happened with YY Inc. (ADR) (Nasdaq: YY). The firm went public in December 2012, and KWEB got on board.
In fact, the fund has invested 3.4% of its assets in YY, which despite the market's recent weakness is up nearly 450% since the stock began trading in the U.S.
- [By Tom Taulli]
So what are the overlooked social stocks to take a look at? Here are the top three:
YY (YY)Based in China, YY (YY) operates a social media platform that allows users to communicate in real-time via voice, text and video. Some of the activities include karaoke, online games, music concerts and even e-learning.
- [By Belinda Cao]
YY Inc. (YY), a social-network operator also based in Guangzhou, jumped 5.8 percent May 3 to $18.30, the highest level since March 6. Sales grew 131 percent in the first quarter from a year earlier, according to a May 2 statement.
- [By Kevin Chen]
YY (NASDAQ: YY ) has added two independent directors to its board of directors. The China-based video social network now has a total of nine directors overseeing the company's strategy and finances.
10 Best Rising Stocks To Watch For 2014: Douglas Dynamics Inc.(PLOW)
Douglas Dynamics, Inc. designs, manufactures, and sells snow and ice control equipment for light trucks in North America. It principally offers snowplows, sand and salt spreaders, and related parts and accessories. The company sells its products under the WESTERN, FISHER, and BLIZZARD brands. Douglas Dynamics sells its products through a distributor network primarily to professional snowplowers. The company was founded in 2004 and is headquartered in Milwaukee, Wisconsin.
Advisors' Opinion:- [By Jon C. Ogg]
Douglas Dynamics Inc. (NYSE: PLOW) was downgraded to Underperform from an already cautious Neutral rating at Credit Suisse, and the target price is $14, versus a current $14.72 share price.
- [By Rich Smith]
Milwaukee-based Douglas Dynamics (NYSE: PLOW ) is bulking up its snow control business.
The maker of Western, Fisher, and Blizzard-brand snowplows, sand and salt spreaders, and related accessories announced Monday that it has acquired "substantially all" assets of truck-mounted salt and sand spreader manufacturer TrynEx, which owns the SnowEx brand.
- [By Monica Gerson]
Douglas Dynamics (NYSE: PLOW) is estimated to post its Q4 earnings at $0.25 per share on revenue of $57.68 million.
SIGA Technologies (NASDAQ: SIGA) is expected to post its Q4 earnings at $0.62 per share on revenue of $47.00 million.
10 Best Rising Stocks To Watch For 2014: Barclays PLC (GRN)
Barclays PLC (Barclays) is a global financial services provider engaged in retail banking, credit cards, wholesale banking, investment banking, wealth management and investment management services. The Company�� operations include its overseas offices, subsidiaries and associates. The Company operates in eight segments: UK Retail and Business Banking (UK RBB), Europe Retail and Business Banking (Europe RBB), Africa Retail and Business Banking (Africa RBB), Barclaycard, Barclays Investment Bank, Barclays Corporate Banking, Wealth and Investment Management, and Head Office and Other Operations. Advisors' Opinion:- [By Todd Shriber, ETF Professor]
Big losers (down at least 5%): Direxion Daily Gold Miners Bear 3X Shares (NYSE: DUST), iPath Global Carbon ETN (NYSE: GRN), iShares MSCI Emerging Markets Value ETF (NYSE: EVAL) and the PureFunds ISE Mining Service ETF (NYSE: MSXX).
- [By Brian Pacampara]
Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, the iPath Global Carbon ETN (NYSEMKT: GRN ) has received the dreaded one-star ranking.
No comments:
Post a Comment